TAVI in bicuspid aortic valve disease

Facilitators: A. Linke, R. Sharma

Summary

Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.

Presentations available when logged in:

  • Long-term outcomes of type 0 BAV patients compared to type 1 BAV and TAV patients after TAVI
  • High residual gradients after TAVI in Raphe-type bicuspid aortic valve stenosis
  • Measured and predicted PPM after TAVI in Sievers type 1 bicuspid aortic valve
  • Comparison between R-L and R-NC BAV treated with TAVI: insight from the international AD HOC registry